Intellectual Property India Publishes Patent Application for 'Bicyclic Ureas As Kinase Inhibitors' Filed by Incyte Corporation

MUMBAI, India, Nov. 14 -- Intellectual Property India has published a patent application (202517096130 A) filed by Incyte Corporation, Wilmington, U.S.A., on Oct. 6, for 'bicyclic ureas as kinase inhibitors.'

Inventor(s) include Li, Xin; Vechorkin, Oleg; Ai, Yanran; Atasoylu, Onur; Dang, Hang Thi; Douty, Brent; He, Chunhong; He, Peng; Liang, Michael; Nguyen, Minh; Styduhar, Evan; Wang, Anlai; Wang, Xiaozhao; Ye, Hai Fen; Yue, Eddy W; Zhang, Ke; and Zhao, Peng.

The application for the patent was published on Nov. 14, under issue no. 46/2025.

According to the abstract released by the Intellectual Property India: "The present application provides bicyclic urea compounds that modulate the activity of JAK2, which are useful in the treatment of various diseases, including cancer."

The patent application was internationally filed on Mar. 12, 2024, under International application No.PCT/US2024/019525.

Disclaimer: Curated by HT Syndication.